Current cell-based influenza vaccine production technology as pandemic contingency (Q30414391)

21 June 2017

Current cell-based influenza vaccine production technology as pandemic contingency (English)

1 reference

21 June 2017

0 references

1 reference

Say Kong Ng

1

1 reference

21 June 2017

1 February 2012

1 reference

Human Vaccines & Immunotherapeutics

21 June 2017

1 reference

21 June 2017

8

1 reference

21 June 2017

2

1 reference

21 June 2017

267-271

1 reference

CULTIVATION OF HUMAN INFLUENZA VIRUS IN AN ARTIFICIAL MEDIUM.

21 June 2017

1 reference

Structural changes in the haemagglutinin which accompany egg adaptation of an influenza A(H1N1) virus

21 January 2018

1 reference

Direct isolation in eggs of influenza A (H1N1) and B viruses with haemagglutinins of different antigenic and amino acid composition

21 January 2018

1 reference

Comparison of 10 influenza A (H1N1 and H3N2) haemagglutinin sequences obtained directly from clinical specimens to those of MDCK cell- and egg-grown viruses

21 January 2018

1 reference

Efficacy of inactivated influenza A virus (H3N2) vaccines grown in mammalian cells or embryonated eggs

21 January 2018

1 reference

Plaque Formation by Influenza Viruses in the Presence of Trypsin

21 January 2018

1 reference

Multiplication of Vaccinia Virus in Serum-free and Serum-containing Cell Cultures

21 January 2018

1 reference

Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness

21 January 2018

1 reference

Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus

21 January 2018

1 reference

Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia.

21 January 2018

1 reference

Development of a mammalian cell (Vero) derived candidate influenza virus vaccine

21 January 2018

1 reference

WHO initiative to increase global and equitable access to influenza vaccine in the event of a pandemic: supporting developing country production capacity through technology transfer

21 January 2018

1 reference

Influenza vaccines based on virus-like particles

21 January 2018

1 reference

Conserved epitopes of influenza A virus inducing protective immunity and their prospects for universal vaccine development

21 January 2018

1 reference

Production of cell culture (MDCK) derived live attenuated influenza vaccine (LAIV) in a fully disposable platform process

21 January 2018

1 reference

Use of MDCK cells for production of live attenuated influenza vaccine

21 January 2018

1 reference

Serum-free microcarrier based production of replication deficient influenza vaccine candidate virus lacking NS1 using Vero cells

21 January 2018

1 reference

Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach

21 January 2018

1 reference

Attenuated influenza virus vaccines with modified NS1 proteins

21 January 2018

1 reference

Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses

21 January 2018

1 reference

National prevalence and risk factors for food allergy and relationship to asthma: results from the National Health and Nutrition Examination Survey 2005-2006.

21 January 2018

1 reference

MDCK and Vero cells for influenza virus vaccine production: a one-to-one comparison up to lab-scale bioreactor cultivation.

21 January 2018

1 reference

Continuous cell lines as a production system for influenza vaccines.

21 January 2018

1 reference

Serum-free influenza virus production avoiding washing steps and medium exchange in large-scale microcarrier culture.

21 January 2018

1 reference

Wave microcarrier cultivation of MDCK cells for influenza virus production in serum containing and serum-free media.

21 January 2018

1 reference

Development of cell culture (MDCK) live cold-adapted (CA) attenuated influenza vaccine

21 January 2018

1 reference

Downstream processing of Vero cell-derived human influenza A virus (H1N1) grown in serum-free medium

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.4161/HV.18336

1 reference

21 June 2017

1 reference

PubMed ID

22426381